Navigation Links
Synteract Appoints Keith Kelson as Chief Financial Officer and Member of Executive Council and Philip Doren, Ph.D., as Vice President, Biometrics
Date:1/30/2013

SAN DIEGO, Jan. 30, 2013 /PRNewswire/ -- Synteract, a leading full service contract research organization (CRO), has hired new executives to support customers on a global scale. Keith Kelson will serve as chief financial officer and member of its executive council, and Phil Doren has been appointed vice president, biometrics. They were chosen for their expertise and leadership acumen in their respective fields; Kelson has executive financial experience in a variety of roles and industries and Doren has more than 20 years of global clinical development experience.

(Logo:  http://photos.prnewswire.com/prnh/20111108/MM02925LOGO)

Kelson will be managing the company's financial portfolio and business affairs. He brings more than 12 years of experience to the role of chief financial officer. Prior to this position, Kelson served as executive vice president and chief financial officer for Insight Health Services Holdings Corporation, a diagnostic imaging firm with more than 1,300 employees and $180 million in revenue,  achieving a dramatic turnaround in profitability and increasing productivity. Prior to that, Kelson served as chief financial officer at SecurusTechnologies, a $400 million telecommunications and software company. Kelson holds a bachelor's degree in accounting from Texas Christian University and has been a certified public accountant since 1991.

Doren will be responsible for overseeing the biostatistics, data management and IT services departments, in order to provide executive oversight and continuity. Doren's 20 years of clinical development experience led to the creation of this new executive position. His experience has been garnered at clinical research organizations, including his most recent position as vice president, clinical data, analysis and reporting organization (CDARO) at Covance. He has also held executive positions with Quintiles, eRT, TKL Research and Kendle. Doren has a doctorate in animal breeding from Texas A&M University.

According to CEO Wendel Barr, the new executives will be pivotal to Synteract's plans for continued growth and expansion.

"Synteract is well-respected in the industry for providing our clients service excellence tailored to their specific drug and device development needs. Keith and Phil will augment and complement the strong leadership team that we have in place to serve a broad spectrum of pharma and biotech companies. The leadership acumen and industry expertise that both Phil and Keith bring to the table allows us to further enhance the quality and continuum of service that is critical to meeting the expectations of our clients' current and future needs, on an international scale."

Synteract announced in late 2012 that it plans to acquire multi-national CRO Harrison Clinical Research. The acquisition will provide Synteract with additional resources and scale to support global programs and the ability to assist clients throughout their entire development life cycle, from emerging products through post-marketing.

About Synteract (www.synteract.com)

Synteract is a full-service contract research organization with a successful 17-year track record supporting biotechnology, medical device and pharmaceutical companies in all phases of clinical development. With its "Shared Work – Shared Vision" philosophy Synteract provides customized Phase I through IV services collaboratively and cost effectively to ensure on-time delivery of quality data so clients get to decision points faster. Headquartered in California, with offices in North Carolina and the Czech Republic, Synteract delivers trials internationally, offering expertise across multiple therapeutic areas including notable depth in oncology, CNS, cardiovascular, respiratory and ophthalmology.

CONTACT:
Rachel Hutman
rachel@clearpointagency.com
760-230-2424


'/>"/>
SOURCE Synteract
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Synteract Leadership to Provide Insights at Industry Events on Both West and East Coasts
2. Synteract Senior Director Olivia Montano Honored as One of the PharmaVOICE 100
3. Synteract Sponsoring and Presenting at Outsourcing in Clinical Trials Southeast Conference
4. Synteract and Rempex Partner in "Great Strides" Walk to Support Cystic Fibrosis Cure
5. Questcor Pharmaceuticals Appoints Michael Aldridge to the Position of Senior Vice President, Corporate Strategic Development
6. Agendia Appoints Dr. Neil M. Barth MD, FACP, as Chief Medical Officer
7. Aratana Therapeutics Appoints Erick Lucera Vice President of Corporate Development
8. China Botanic Appoints Jack Zhao as Independent Director
9. AAIPharma Appoints Senior Director of Parenteral Operations
10. ComSec LLC Appoints Keesling Director of New Healthcare Cyber Defense Initiative
11. Strand Diagnostics appoints new President
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... 27, 2016  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ... whatever measures required to build a strong and stable ... currently listed on the OTC Markets-pink current trading platform. ... CEO, "We are seeing an anomaly in market trading ... only by the Company, but shareholders and market players ...
(Date:6/24/2016)... June 24, 2016   Bay Area Lyme ... Dean Center for Tick Borne Illness , ... Rehabilitation, MIT Hacking Medicine, University of California, Berkeley, ... announced the five finalists of Lyme Innovation ... More than 100 scientists, clinicians, researchers, entrepreneurs, and ...
(Date:6/24/2016)... SAN CLEMENTE, Calif. , June 24, 2016  American ... function testing company, is now able to perform sophisticated lung assessments ... ndd Medical Technologies , Inc. Patients are no ...  Thanks to ndd,s EasyOne PRO ® , ARL patients like Jeanne ... needed testing done in the comfort of her own home. ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... 25, 2016 , ... Experts from the American Institutes for ... Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR ... care planning, healthcare costs and patient and family engagement. , AIR researchers will ...
(Date:6/25/2016)... CA (PRWEB) , ... June 25, 2016 , ... As ... with Magna Cum Laude and his M.D from the David Geffen School of Medicine ... and returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set ... drug or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, ... traumatic event. , Trauma sufferers tend to feel a range of emotions, from depression, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile technology, ... , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can be ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty Network, affiliated ... Weintraub as a prominent plastic surgeon and the network’s newest partner. , ... most handsome men, look naturally attractive. Plastic surgery should be invisible.” He stands ...
Breaking Medicine News(10 mins):